Drug Use-Results Survey of Gonalef (subcutaneous injection) for Induction of Spermatogenesis in Male Hypogonadotropic Hypogonadism Patients
Not Applicable
- Conditions
- Male Hypogonadotropic Hypogonadism
- Registration Number
- JPRN-UMIN000032963
- Lead Sponsor
- Merck Serono Co., Ltd. PMS Planning & Strategy, Medical Department
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 300
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who do not give a full consent to this survey.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method